Quarterly report pursuant to Section 13 or 15(d)

Supplemental Information to Condensed Consolidated Statements of Cash Flows (Detail)

v3.8.0.1
Supplemental Information to Condensed Consolidated Statements of Cash Flows (Detail) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Supplemental Cash Flow Elements [Abstract]    
Cash paid for interest $ 58,334 $ 68,552
Cash paid for income taxes, net of refunds received 81,271 66,757
Noncash investing and financing activities:    
Change in accounts payable and accrued expenses for the acquisition of theatre properties and equipment [1] (5,947) 132
Theatre properties acquired under capital lease 30,517 11,292
Investment in NCM – receipt of common units (see Note 6) 18,363 11,111
Dividends accrued on unvested restricted stock unit awards $ (423) [2] $ (360) [3]
[1] Additions to theatre properties and equipment included in accounts payable as of September 30, 2017 and December 31, 2016 were $34,678 and $40,625, respectively.
[2] Below is a summary of dividends paid to stockholders and accrued on unvested restricted stock unit awards during the nine months ended September 30, 2017: Amount per Share Declaration Date Record Date Payable Date of Common Stock Total 2/23/2017 3/8/2017 3/20/2017 $0.29 $33,912 5/25/2017 6/8/2017 6/22/2017 0.29 33,904 8/10/2017 8/31/2017 9/13/2017 0.29 33,911 Total $0.87 $101,727
[3] Below is a summary of dividends paid to stockholders and accrued on unvested restricted stock unit awards during the nine months ended September 30, 2016: Amount per Share Declaration Date Record Date Payable Date of Common Stock Total 2/24/2016 3/7/2016 3/18/2016 $0.27 $31,367 5/26/2016 6/8/2016 6/22/2016 0.27 31,373 8/18/2016 8/31/2016 9/13/2016 0.27 31,737 Total $0.81 $94,477